Sannino Anna, Ilardi Federica, Hahn Rebecca T, Toufan Mehrnoush, Nickolite Katie, Agarwal Vratika, Havens Benjamin, Ku Ivy, Silvestry Frank, Weckbach Ludwig, Gleason Patrick, Pretorius Mias, Ho Edwin, Tulloch John, Ruf Tobias, Cohen Joshua, Duggal Neal, Sengupta Partho P, Kelly Noreen, Chehab Bassem M, Vogelhuber Johanna, Vad Siddharth, Deuschl Florian, Thourani Vinod H, Lurz Philipp, Kodali Susheel K, Grayburn Paul A
Baylor Scott and White Cardiovascular Imaging Core Laboratory, Baylor Scott and White-The Heart Hospital, Plano, Texas, USA.
Baylor Scott and White Cardiovascular Imaging Core Laboratory, Baylor Scott and White-The Heart Hospital, Plano, Texas, USA.
JACC Cardiovasc Imaging. 2025 Jul 28. doi: 10.1016/j.jcmg.2025.06.011.
The transcatheter EVOQUE tricuspid valve replacement system is an approved device for the treatment of patients with symptomatic severe tricuspid regurgitation despite medical therapy both in the United States and in Europe. Specific imaging requirements are needed in the screening and in the intraprocedural phase as well as to assess this valve after implantation, in order to assess its positioning and performance. In this review, focus will be on the postoperative echocardiographic assessment of device positioning and stability; evaluation of residual central tricuspid regurgitation or paravalvular leak; valve thrombosis/degeneration; interaction of the device frame with the right ventricle and adjacent structures, including the aortic valve and interventricular septum; and placement of pacemaker leads. This review will therefore be centered on these essential imaging aspects in the echocardiographic postimplantation evaluation of the EVOQUE valve.
经导管EVOQUE三尖瓣置换系统在美国和欧洲都是一种已获批准的用于治疗尽管接受了药物治疗仍有症状性严重三尖瓣反流患者的装置。在筛查、手术过程中以及植入后评估该瓣膜时，都需要特定的成像要求，以便评估其定位和性能。在本综述中，重点将放在术后超声心动图对装置定位和稳定性的评估；残余中心三尖瓣反流或瓣周漏的评估；瓣膜血栓形成/退化；装置框架与右心室及相邻结构（包括主动脉瓣和室间隔）的相互作用；以及起搏器导线的放置。因此，本综述将围绕EVOQUE瓣膜植入后超声心动图评估中的这些重要成像方面展开。
